Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets.

Source:http://linkedlifedata.com/resource/pubmed/id/18068154

Eur. J. Pharmacol. 2008 Feb 12 580 3 285-90

Download in:

View as

General Info

PMID
18068154